Mean platelet volume could be possible biomarker in early diagnosis and monitoring of gastric cancer

Platelets

Volumn 25, Issue 8, 2014, Pages 592-594

  Kilinҫalp, Serta ^a   Ekiz, Fuat ^a   Başar, Ömer ^a,b   Ayte, Mehmet Raşit ^a   Çoban, Şahin ^a   Yilmaz, Bariş ^a   Altinbaş, Akif ^a   Ba¸sar, Nurcan ^b   Aktaş, Bora ^a   Tuna, Yaşar ^b   Erbiş, Halil ^c   Uҫar, Engin ^a   Erarslan, Elife ^a   Yüksel, Osman ^a  

^a DISKAPI YILDIRIM BEYAZIT TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b AKDENIZ UNIVERSITY   (Turkey)

^c PAMUKKALE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Gastric cancer; Gastric surgery; Mean platelet volume

Indexed keywords

BIOLOGICAL MARKER; TUMOR MARKER;

AGED; ARTICLE; CANCER STAGING; CANCER SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE MARKER; EARLY DIAGNOSIS; FEMALE; HUMAN; MALE; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PREOPERATIVE PERIOD; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; STOMACH CANCER; THROMBOCYTE VOLUME; ADVERSE EFFECTS; BLOOD; METABOLISM; MIDDLE AGED; MORTALITY; STOMACH NEOPLASMS;

AGED; FEMALE; HUMANS; MALE; MEAN PLATELET VOLUME; MIDDLE AGED; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84908893774     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.3109/09537104.2013.783689     Document Type: Article

References (33)

1. Brenner H, Rothenbacher D, Arndt V. Epidemiology of stomach cancer. Methods Mol Biol 2009;472:467.
2. Shim KN, Jung SA, Joo YH, Yoo K. Clinical significance of tissue levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in gastric cancer. J Gastroenterol 2007;42: 120-128.
3. Mroczko B, Groblewska M, Łukaszewicz-Zajac M, Kedra B, Szmitkowski M. Pre-treatment serum and plasma levels of matrix metalloproteinase 9 (MMP-9) and tissue inhibitor of matrix metalloproteinases 1 (TIMP-1) in gastric cancer patients. Clin Chem Lab Med 2009;47:1133-1139.
4. Mroczko B, Wereszczynska-Siemiatkowska U, Groblewska M, Lukaszewicz M, Szmitkowski M, Gryko M, Kedra B. The diagnostic value of hematopoietic cytokines measurement in the sera of gastric cancer and gastric ulcer patients. Clin Chim Acta 2006;374: 165-167.
5. Lochhead P, El-Omar EM. Gastric cancer. Br Med Bull 2008;85: 87-100.
6. Ilhan N, Ilhan Y, Akbulut H, Kucuksu M. C-reactive protein, procalcitonin, interleukin-6, vascular endothelial growth factor and oxidative metabolites in diagnosis of infection and staging in patients with gastric cancer. World J Gastroenterol 2004;10: 1115-1120.
7. Kim DK, Oh SY, Kwon HC, Lee S, Kwon KA, Kim BG, Kim SG, Kim SH, Jang JS, Kim MC, et al. Clinical significances of preoperative serum interleukin-6 and C-reactive protein level in operable gastric cancer. BMC Cancer 2009;9:155.
8. Bath PM, Butterworth RJ. Platelet size: Measurement, physiology and vascular disease. Blood Coagul Fibrinolysis 1996;7:157-161.
9. Kai H, Kitadai Y, Kodama M, Cho S, Kuroda T, Ito M, Tanaka S, Ohmoto Y, Chayama K. Involvement of proinflammatory cytokines IL-1beta and IL-6 in progression of human gastric carcinoma. Anticancer Res 2005;25:709-713.
10. Tekbas E, Kara AF, Ariturk Z, Cil H, Islamoglu Y, Elbey MA, Soydinc S, Ulgen MS. Mean platelet volume in predicting short- and long-term morbidity and mortality in patients with or without ST-segment elevation myocardial infarction. Scand J Clin Lab Invest 2011;71:613-619.
11. Sen N, Basar N, Maden O, Ozcan F, Ozlu MF, Gungor O, Cagli K, Erbay AR, Balbay Y. Increased mean platelet volume in patients with slow coronary flow. Platelets 2009;20:23-28.
12. Greisenegger S, Endler G, Hsieh K, Tentschert S, Mannhalter C, Lalouschek W. Is elevated mean platelet volume associated with a worse outcome in patients with acute ischemiccerebrovascular events? Stroke 2004;35:1688-1691.
13. Ekiz F, Yüksel O, Koc¸ak E, Yilmaz B, Altinbaş A, Çoban Ş, Yüksel I, Üsküdar O, Köklü S. Mean platelet volume as a fibrosis marker in patients with chronic hepatitis B. J Clin Lab Anal 2011; 25:162-165.
14. Yüksel O, Helvaci K, Başar O, Köklü S, Caner S, Helvaci N, Abayli E, Altiparmak E. An overlooked indicator of disease activity in ulcerative colitis: Mean platelet volume. Platelets 2009;20: 277-281.
15. Ekiz F, Gürbüz Y, Basar O, Aytekin G, Ekiz O, Sentürk GC, Aktas B, Yilmaz B, Altinbas A, Coban S, et al. Mean platelet volume in the diagnosis and prognosis of crimean-congo hemorrhagic fever. Clin Appl Thromb Hemost. 2012 Mar 19. [Epub ahead of print].
16. Purnak T, Olmez S, Torun S, Efe C, Sayilir A, Ozaslan E, Tenlik I, Kalkan IH, Beyazit Y, Yuksel O. Mean platelet volume is increased in chronic hepatitis C patients with advanced fibrosis. Clin Res Hepatol Gastroenterol 2013;37:41-46.
17. Purnak T, Efe C, Yuksel O, Beyazit Y, Ozaslan E, Altiparmak E. Mean platelet volume could be a promising biomarker to monitor dietary compliance in celiac disease. Ups J Med Sci 2011;116: 208-211.
18. Kurt M, Onal IK, Sayilir AY, Beyazit Y, Oztaş E, Kekilli M,Turhan N, Karaman K, Akdogan M. The role of mean platelet volume in the diagnosis of hepatocellular carcinoma in patients with chronic liver disease. Hepatogastroenterology 2012;59:1580-1582.
19. Karaman K, Bostanci EB, Aksoy E, Kurt M, Celep B, Ulas M, Dalgic T, Surmelioglu A, Hayran M, Akoglu M. The predictive value of mean platelet volume in differential diagnosis of non-functional pancreatic neuroendocrine tumors from pancreatic adenocarcinomas. Eur J Intern Med 2011;22:95-98.
20. Edge SB, Compton CC. The American Joint Committee on Cancer: The 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 2010;17:1471-1474.
21. Mizoue T, Yoshimura T, Tokui N, Hoshiyama Y, Yatsuya H, Sakata K, Kondo T, Kikuchi S, Toyoshima H, Hayakawa N, et al; Japan Collaborative Cohort Study Group. Prospective study of screening for stomach cancer in Japan. Int J Cancer 2003;106:103.
22. Llorens P. Gastric cancer mass survey in Chile. Semin Surg Oncol 1991;7:339.
23. Pisani P, Oliver WE, Parkin DM, Alvarez N, Vivas J. Case-control study of gastric cancer screening in Venezuela. Br J Cancer 1994;69: 1102.
24. Carpelan-Holmström M, Louhimo J, Stenman UH, Alfthan H, Haglund C. CEA, CA 19-9 and CA 72-4 improve the diagnostic accuracy in gastrointestinal cancers. Anticancer Res 2002; 22:2311.
25. Lai IR, Lee WJ, Huang MT, Lin HH. Comparison of serum CA72-4, CEA, TPA, CA19-9 and CA125 levels in gastric cancer patients and correlation with recurrence. Hepatogastroenterology 2002;49:1157.
26. Lochhead P, El-Omar EM. Gastric cancer. Br Med Bull 2008;85: 87-100.
27. Hussain SP, Harris CC. Inflammation and cancer: An ancient link with novel potentials. Int J Cancer 2007;121:2373-2380.
28. Galizia G, Lieto E, De Vita F, Romano C, Orditura M, Castellano P, Imperatore V, Infusino S, Catalano G, Pignatelli C. Circulating levels of interleukin-10 and interleukin-6 in gastric and colon cancer patients before and after surgery: Relationship with radicality and outcome. J Interferon Cytokine Res 2002;22:473-482.
29. Shariat SF, Andrews B, Kattan MW, Kim J, Wheeler TM, Slawin KM. Plasma levels of interleukin-6 and its soluble receptor are associated with prostate cancer progression and metastasis. Urology 2001;58:1008-1015.
30. Ashizawa T, Okada R, Suzuki Y, Takagi M, Yamazaki T, Sumi T, Aoki T, Aoki T. Clinical significance of interleukin-6 (IL-6) in the spread of gastric cancer: Role of IL-6 as a prognostic factor. Gastric Cancer 2005;8:124-131.
31. Wu CW, Wang SR, Chao MF, Wu TC, Lui WY, P'eng FK, Chi CW. Serum interleukin-6 levels reflect disease status of gastric cancer. Am J Gastroenterol 1996;91:1417-1422.
32. Hsu HC, Lee YM, Tsai WH, Jiang ML, Ho CH, Ho CK, Wang SY. Circulating levels of thrombopoietic and inflammatory cytokines in patients with acute myeloblastic leukemia and myelodysplastic syndrome. Oncology 2002;63:64-69.
33. Osada J, Rusak M, Kamocki Z, Dabrowska MI, Kedra B. Platelet activation in patients with advanced gastric cancer. Neoplasma 2010;57:145-150.